The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeted DNA and RNA sequencing of paired urothelial and squamous bladder cancers to reveal discordant genomic and transcriptomic events and unique therapeutic opportunities.
 
Daniel H. Hovelson
Travel, Accommodations, Expenses - Thermo Fisher Scientific
 
Lorena Lazo De La Vega
No Relationships to Disclose
 
Andrew McDaniel
No Relationships to Disclose
 
Aaron Udager
No Relationships to Disclose
 
Rohit Mehra
No Relationships to Disclose
 
Ganesh S. Palapattu
Stock and Other Ownership Interests - NantWorks
Consulting or Advisory Role - GenomeDx; Tokai Pharmaceuticals
Research Funding - NantWorks
Patents, Royalties, Other Intellectual Property - implantable nanotechnology for long term testosterone delivery functionalized fiducial marker for drug delivery
Travel, Accommodations, Expenses - Tokai Pharmaceuticals
 
Alon Z. Weizer
No Relationships to Disclose
 
Todd Matthew Morgan
Consulting or Advisory Role - MDxHealth; Myriad Genetics
Research Funding - MDxHealth; Myriad Genetics
 
Jeffrey Scott Montgomery
No Relationships to Disclose
 
Scott A. Tomlins
Leadership - Strata Oncology
Stock and Other Ownership Interests - Strata Oncology
Honoraria - Abbvie; Astellas Medivation; Janssen; Roche; Sanofi; Ventana Medical Systems
Consulting or Advisory Role - Abbvie; Astellas Medivation; Janssen; Roche; Strata Oncology; Ventana Medical Systems
Research Funding - Astellas Medivation (Inst); Compendia Bioscience (Inst); GenomeDx (Inst); Life Technologies (Inst); Thermo Fisher Scientific (Inst)
Patents, Royalties, Other Intellectual Property - I am a coauthor on a patent issued to the University of Michigan on ETS gene fusions in prostate cancer. The diagnostic field of use has been licensed to Hologic/Gen-Probe Inc., who has sublicensed some rights to Ventana Medical Systems/Roche.
Travel, Accommodations, Expenses - Compendia Bioscience; Life Technologies; Thermo Fisher Scientific